SHANGHAI, China, Feb. 11 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, announced today that the company was selected in Deloitte Technology Fast 500 Asia Pacific list. Deloitte selects and publishes Technology Fast 500 list every year for regions such as North America, Europe, and Asia Pacific, to recognize in each region the technology companies that have achieved the fastest revenue growth in the past three years. Deloitte also publishes a Technology Fast 50 list for China in recent years. For year 2008, Sundia ranked #52 in Deloitte Technology Fast 500 Asia Pacific list, and #16 in Fast 50 China list, with its 928% revenue growth.
In its 5-year history, Sundia has established a strong brand image in global pharmaceutical CRO industry, especially in new drug discovery services. "We are honored to be among the 500 fastest growth technology companies in Asia Pacific. This award is a recognition of our business model and our team's effort," said Dr. Xiaochuan Wang, CEO of Sundia.
About Sundia MediTech
Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 5 years, Sundia has built a strong reputation as a leading CRO Company in China.
|SOURCE Sundia MediTech Company|
Copyright©2009 PR Newswire.
All rights reserved